Riskpilot← Back to searchSign inGet full accessTØNSBERG MEDISINSKE SENTER AS
ASActiveOrg 981697979Kilengaten 18, 3117 TønsbergRental and operating of own or leased real estate · NACE 6820Est. 20000 employees
Revenue 2024
NOK 376K
-60% vs 2023
EBITDA margin
9.1%
+186% vs 2023
Equity ratio
86.2%
Financial strength
Net profit 2024
NOK 36K
+200% vs 2023
| Revenue | NOK 376K | -60% |
| EBITDA | NOK 34K | +186% |
| Net profit | NOK 36K | +200% |
| Total assets | NOK 166K | +32% |
| Equity | NOK 143K | +41% |
| Employees | 0 | — |
Legal name
TØNSBERG MEDISINSKE SENTER AS
Org number
981697979
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
6. april 2000
Share capital
NOK 118 151
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å samle virksomheter innen helse- og sosialmedisin i tønsberg samt drive et medisinsk senter med målsetting om et godt faglig og sosialt fellesskap med et helhetlig tilbud til pasienter og med nært samarbeid og kommunikasjon mellom faggrupper og kolleger. Videre skal selskapet kunne drive handels og konsulent virksomhet samt hva herved står i forbindelse, herunder å delta i andre selskaper med liknende virksomhet.
Address
Kilengaten 18, 3117 Tønsberg
Phone
+4733376300
Email
tms@tms.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 039 | 2 884 | 2 979 | 932 | 376 |
| Staff expenses | −412 | −377 | −396 | −69 | −24 |
| EBITDA | 158 | −37 | −110 | −40 | 34 |
| Depreciation & amort. | −6 | −6 | −0 | −0 | −0 |
| EBIT | 152 | −42 | −110 | −40 | 34 |
| Net financials | 7 | 7 | 4 | 3 | 2 |
| Profit before tax | 159 | −36 | −106 | −36 | 36 |
| Tax | 19 | −1 | −0 | −0 | −0 |
| Net profit | 140 | −35 | −106 | −36 | 36 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 737 | 724 | 602 | 126 | 166 |
| Equity | 577 | 533 | 118 | 102 | 143 |
| Long-term debt | 1 | 0 | 0 | 0 | 0 |
| Short-term debt | 159 | 191 | 483 | 24 | 23 |
| Total debt | 160 | 191 | 483 | 24 | 23 |
EBITDA margin
9.1%
This company
15.8%
Market median
-42% vs market
20202024
Equity ratio
86.2%
This company
38.2%
Market median
+126% vs market
20202024
Return on equity
25.2%
This company
18.4%
Market median
+37% vs market
20202024
Net profit margin
9.6%
This company
8.1%
Market median
+19% vs market
20202024
Asset turnover
2.26×
This company
1.12×
Market median
+102% vs market
20202024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ØN Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (2) | ||
CS Deputy Member | Deputy Member | 2021 – 2022 |
IL Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairman | 2025 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Board of Directors | 2023 – 2025 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 13.64% | 13.64% | 2024 | |
| Company | 13.63% | 13.63% | 2024 | |
| Individual | 11.54% | 11.54% | 2022 | |
| Individual | 6.06% | 6.06% | 2024 | |
| Individual | 6.06% | 6.06% | 2024 | |
| Individual | 6.06% | 6.06% | 2024 | |
| Company | 4.55% | 4.55% | 2024 | |
| Individual | 4.55% | 4.55% | 2024 | |
| Individual | 4.55% | 4.55% | 2024 | |
| Individual | 4.55% | 4.55% | 2024 | |
| Company | 4.55% | 4.55% | 2024 | |
| Individual | 4.55% | 4.55% | 2024 | |
| Individual | 4.55% | 4.55% | 2024 | |
| Individual | 4.55% | 4.55% | 2024 | |
| Individual | 4.55% | 4.55% | 2024 | |
| Individual | 4.55% | 4.55% | 2024 | |
| Individual | 4.55% | 4.55% | 2024 | |
| Individual | 4.55% | 4.55% | 2024 | |
| Individual | 2.34% | 2.34% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TØNSBERG MEDISINSKE SENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Smedsrud | Deputy Member | 0 companies |
| Ingvar Lona | Chief Executive Officer | 0 companies |
| Øyvind Nilsson | Chief Executive Officer | 0 companies |
| Valentin Jørstad | Board of Directors | 0 companies |
| Bent Njøten | Board of Directors | 0 companies |
| Ingrid Elise Veseth | Board of Directors | 0 companies |
| Thomas Solberg | Chairman | 0 companies |
| Turid Bryn | Board of Directors | 0 companies |